CD274 and neoplasm: TAMs exhibit an immunosuppressive gene profile typical of monocytic MSDCs and notably express several immune checkpoint molecules that are potential therapeutic targets, such as PD-L1 and LILRB receptors (89, 90), which are absent on tumor cells.